Navigation Links
Quantum OPS Completes $1.05M In Series A Financing To Advance Surgical Devices
Date:6/28/2012

PITTSBURGH, June 28, 2012 /PRNewswire/ -- Quantum OPS, INC., the orthopedic technology company for today's sophisticated operating suite professionals, announced the closing of a $1.05M Series A financing round. The round was led by the Pittsburgh Life Science Greenhouse (PLSG) and the PLSG Accelerator Fund with additional funding from multiple institutional and angel investors. Invested capital will accelerate sales of Quantum OPS first product, the Quantum Shoulder Positioning System, which enables clinicians to easily immobilize, stabilize, and position patients of all sizes for shoulder surgery. It will also hasten the launch of new products. Quantum OPS current development pipeline includes a surgical arm positioner, an arthroscopic knee positioner, and other positioning accessories.

"Today's orthopedic patients are larger, budgets are smaller, and expectations are higher," said Keith Harper, CEO of Quantum OPS. "This is an exciting time for Quantum OPS. Our shoulder positioner is just the beginning. This financing will allow us to plan for and launch another generation of products. This will position us to fulfill more unmet clinical needs for our customers and reward our investors with profitable growth."

Quantum OPS provides 21st century simple and efficient clinical solutions to meet the rapidly evolving needs of today's orthopedic surgical suite. Functionality across all patient types, stability, ease, and speed of use are the foundation of Quantum OPS design philosophy. The Quantum Shoulder Positioning System was released to select accounts in January, 2012, and will be available nationwide later this summer. The Positioner features both single-use disposable and re-usable elements.

"Quantum OPS has a superior technology and a team with the vision and ability to deliver on a huge opportunity.  We and our investment partners look forward to the continued growth and success of this promising portfolio company," said John W. Manzetti, PLSG President & CEO and Founder and Managing Director of the PLSG Accelerator Fund.

About Quantum OPS 
QuantumOPS is an orthopedic technology company for today's sophisticated operating suite professionals. Our products combine ingenuity and 21st century technology designed to deliver superior clinical outcome for patients, surgeons, nurses and anesthesiologists everywhere. We involve the user in every step of the design process from conception to completion to deliverable goods. Quantum OPS prides itself on its exceptional agility and responsiveness to market need. www.quantumops.com

About the Pittsburgh Life Sciences Greenhouse (PLSG) 
PLSG invests in and supports the growth of biosciences companies in western Pennsylvania. PLSG has a track record of excellence when it comes to attracting and growing life sciences companies in the region. Since its inception in 2002, the PLSG has invested $17.6 million in 66 companies which has leveraged $730 million in additional capital to the region. The PLSG portfolio of companies represents an aggregate market valuation which the PLSG believes it conservatively estimates as over $1 billion. The PLSG has assisted 373 life sciences companies and has helped create or retain nearly 6,000 jobs in western Pennsylvania. In addition, 34 companies or venture capital firms have been provided with office or laboratory space and 13 have been relocated to Pittsburgh from outside of the region. www.plsg.com

About The PLSG Accelerator Fund LLC
The PLSG Accelerator Fund I, the for-profit venture capital arm of the Pittsburgh Life Sciences Greenhouse,  provides regional life sciences companies with venture capital financing, which is the next step beyond capital provided by economic development organizations; friends and family; and angel investors. As the only pure life sciences venture capital fund in the region, the Accelerator Fund is building a portfolio of early-stage life sciences investments, primarily located in western Pennsylvania and spread across several life sciences sectors including medical devices, diagnostics, therapeutics, healthcare information technology and biotechnology tools. www.acceleratorfund.com

 

 

 


'/>"/>
SOURCE Quantum OPS
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Ablative Solutions Completes $5.3M Series A Financing
2. Amgen Completes Acquisition of Mustafa Nevzat Pharmaceuticals
3. Jazz Pharmaceuticals Completes EUSA Pharma Acquisition
4. Savara Pharmaceuticals Completes Phase I Clinical Study of AeroVanc in Cystic Fibrosis Patients
5. Bausch + Lomb Completes the Acquisition of ISTA Pharmaceuticals
6. CryoLife Completes Acquisition of Hemosphere
7. NuMe Health Completes $1.5 Million Series A Financing To Advance Its First Cobiotic™ Aimed At Helping Prediabetics Maintain Healthy Blood Glucose Levels
8. Novelos Therapeutics Successfully Completes First Cohort In Phase 1b Solid Tumor Trial With I-131-CLR1404 (HOT) Cancer-Targeted Molecular Radiotherapeutic
9. HeartWare Completes Enrollment In 450-Patient Pivotal Destination Therapy Clinical Trial
10. Benvenue Medical Secures $25 Million Series D Financing
11. Igenica Closes $33 Million in Series C Funding
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/16/2017)... Datascope Corp. is voluntarily performing a worldwide field correction of ... test failure code.     ... PART NUMBER ... 0998-UC-0446HXX; 0998-UC-0479HXX 0998-00-3013-XX;  0998-UC-3013-XX ... This field correction also applies to ...
(Date:6/13/2017)... June 13, 2017 Zimmer Biomet Holdings, Inc. (NYSE ... announced that the U.S. Food and Drug Administration (FDA) has ... 2015 relating to its Zhejiang, China ... "The successful clearance of the Warning Letter related ... facility is a measure of the progress we have made ...
(Date:6/9/2017)... INDIANAPOLIS , June 9, 2017 More ... a further effort to help spread lessons learned from ... the International Diabetes Federation (IDF) and Eli Lilly and ... for the second phase of the Bringing Research in ... reaffirming their commitment to helping people with diabetes effectively ...
Breaking Medicine Technology:
(Date:6/23/2017)... ... June 23, 2017 , ... ... Conference from Sept. 18 to 20. , The two-day conference is focused on ... the goal of improving patients’ lives and eliminating racial breast cancer-related disparities. The ...
(Date:6/23/2017)... ... , ... Ross Insurance Agency ( http://www.rossinsuranceagency.com ) saves clients ... (FEMA) recent update of flood zones, more people than ever are in flood ... to reflect the actual risk in flood zone areas during a time when ...
(Date:6/23/2017)... ... June 23, 2017 , ... Jusino Insurance Services, ... communities in the greater Chicago metropolitan area, is embarking on a charity drive ... in Chicago. , Founded in 1897, Hephzibah Children’s Association is one of the ...
(Date:6/22/2017)... FL (PRWEB) , ... June 22, 2017 , ... Branches, ... received more than $245,000 in grant funding to support its programs focused on providing ... Branches, Inc. was awarded a grant by the Foundation of $15,000 to support its ...
(Date:6/22/2017)... ... June 22, 2017 , ... Children’s National Health System ... (AHA) to launch a Rheumatic Heart Disease Center, with the goal of developing ... heart disease (RHD) in high-risk, financially disadvantaged countries and low-income communities across the ...
Breaking Medicine News(10 mins):